Public Employees for Environmental Responsibility v. Regan

District Court, District of Columbia·Decided December 11, 2024·No. Civil Action No. 2024-2194·Published

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA

PUBLIC EMPLOYEES FOR ENVIRONMENTAL RESPONSIBILITY, et al.,

Plaintiffs, v. Civil Action No. 24-2194 (JEB)

MICHAEL REGAN, et al., Defendants.

MEMORANDUM OPINION

Frustrated by an inert regulatory process and setbacks in other courts, Plaintiffs Public Employees for Environmental Responsibility and Center for Environmental Health have brought this citizen suit under the Toxic Substances Control Act against the Environmental Protection Agency and its administrator, Michael Regan. At base, they seek to compel EPA to prohibit fluorination practices that produce a class of carcinogenic chemicals known as per- and polyfluoroalkyl substances (PFAS), which have been found in fluorinated plastic packaging (think: pesticide containers, bleach bottles, gas cans) manufactured by Inhance Technologies LLC.

The problem for PEER and CEH, however, is that after they filed this action, EPA initiated — at Plaintiffs’ behest — a rulemaking to address the production of PFAS. In moving to dismiss, Defendants argue that this development has mooted Plaintiffs’ primary request for relief. They further contend that the Court lacks jurisdiction to adjudicate Plaintiffs’ additional

demand that EPA seek interim injunctive relief until such rule is effective. Inhance, meanwhile, has filed a Motion to Intervene in the suit and, with it, a Motion to Dismiss for lack of standing. Because the Court agrees with Defendants that they have fulfilled any nondiscretionary duties under the TSCA, it will grant their Motion to Dismiss and deny as moot Inhance’s Motion to Intervene. I. Background The relevant timeline for our narrative begins on March 29, 2023, the date by which Plaintiffs allege EPA possessed “conclusive data” showing both that a certain PFAS known as perfluorooctanoic acid (PFOA) is carcinogenic and that it lurks in the “tens of millions of plastic containers fluorinated by Inhance” that populate the U.S. economy. See ECF No. 1 (Compl.), ¶ 8. Armed with this information, Plaintiffs argue, EPA was obligated by statute to take certain actions to “prevent or reduce to a sufficient extent” the risk posed by PFOA (more on the basis of such obligation later). See 15 U.S.C. § 2603(f).

The agency did so, ordering Inhance in December 2023 either to eliminate PFOA and other PFAS from its fluorination process or to temporarily halt production. See Compl., ¶ 11; Inhance Techs., LLC v. EPA, 96 F.4th 888, 890 (5th Cir. 2024). EPA issued that order under its authority to regulate “significant new uses” of specific categories of PFAS. See 40 C.F.R. § 721.10536; 15 U.S.C. § 2604. Inhance, however, had been using its PFAS-producing fluorination process since 1983. See Inhance, 96 F.4th at 890. The company thus challenged EPA’s order, and, in March of this year, the Fifth Circuit vacated it, concluding that Inhance’s fluorination process was not a “new” use within the meaning of the statute. See id. at 893–95.

Worried that this development left PFAS unregulated, on April 11, 2024, Plaintiffs and other interested groups subsequently filed a petition asking EPA to initiate a rulemaking under

15 U.S.C. § 2605 to prohibit throughout the United States the manufacture and distribution of three PFAS (including PFOA) formed during the fluorination of plastic containers. See ECF No. 14 (MTD) at 7. On July 10, the agency granted that petition, informing Plaintiffs that it would “promptly commence an appropriate proceeding under” § 2605. See ECF No. 14-1 (Pet. Grant) at 2. “As part of that proceeding,” EPA explained, it would first “request information” from the public “to ensure that any risks associated with” the PFAS under consideration “are appropriately evaluated and managed.” Id. at 3.

Plaintiffs, however, found EPA’s proposed course of action unacceptably sluggish. A little over two weeks later, they filed this lawsuit against Defendants under the TSCA’s citizen- suit provision. See Compl.; see also 15 U.S.C. § 2619(a)(2) (authorizing suits against EPA administrator by “any person”). In their first claim for relief, PEER and CEH ask the Court to order EPA to “immediately propose a rule . . . prohibiting the production of PFOA during the Inhance fluorination process.” Compl., ¶ 121. Their second claim asks for an order requiring EPA to commence a suit against Inhance to prohibit the formation of PFOA during the fluorination process or otherwise to “make its proposed rule . . . imposing such a ban immediately effective upon publication in the Federal Register.” Id., ¶ 133.

Two months later, on September 30, 2024, EPA published in the Federal Register a notice seeking public comment as part of its rulemaking to address the risks of PFAS production during the fluorination of plastic containers. See Certain PFAS Risk Management Under the TSCA; Request for Comment, 89 Fed. Reg. 79581 (Sept. 30, 2024). In particular, it sought information regarding the “number, location, and uses of fluorinated containers in the United States”; “alternatives to the fluorination process that generates PFAS”; and “measures to address risk from [PFAS] formed during the fluorination of plastic containers.” Id. at 79582. Such

information, EPA indicated, would “inform the Agency’s path forward with respect to” a rulemaking under § 2605. Id. II. Legal Standard Because the issues in this case straddle the occasionally murky boundary between lack of subject-matter jurisdiction and failure to state a claim, the Court will lay out both standards.

To survive a motion to dismiss under Federal Rule of Civil Procedure 12(b)(1), a plaintiff generally bears the burden of proving that the court has subject-matter jurisdiction to hear its claims. See DaimlerChrysler Corp. v. Cuno, 547 U.S. 332, 342 & n.3 (2006); Arpaio v. Obama, 797 F.3d 11, 19 (D.C. Cir. 2015). A court has an “affirmative obligation to ensure that it is acting within the scope of its jurisdictional authority,” Grand Lodge of Fraternal Order of Police v. Ashcroft, 185 F. Supp. 2d 9, 13 (D.D.C. 2001), which includes the obligation to consider issues of mootness. See Mine Reclamation Corp. v. FERC, 30 F.3d 1519, 1522 (D.C. Cir. 1994). Unlike some other jurisdictional issues, however, the party asserting mootness — here, the Government — bears the burden of establishing that the case is in fact moot. See Honeywell Int’l, Inc. v. NRC, 628 F.3d 568, 576 (D.C. Cir. 2010). Additionally, unlike with a motion to dismiss under Rule 12(b)(6), the court “may consider materials outside the pleadings in deciding whether to grant a motion to dismiss for lack of jurisdiction.” Jerome Stevens Pharms., Inc. v. FDA, 402 F.3d 1249, 1253 (D.C. Cir. 2005).

Free access — add to your briefcase to read the full text and ask questions with AI

Public Employees for Environmental Responsibility v. Regan, (D.D.C. 2024).

Public Employees for Environmental Responsibility v. Regan (Public Employees for Environmental Responsibility v. Regan) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Murphy v. Hunt
455 U.S. 478 (Supreme Court, 1982)
Honig v. Doe
484 U.S. 305 (Supreme Court, 1988)
DaimlerChrysler Corp. v. Cuno
547 U.S. 332 (Supreme Court, 2006)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Sparrow, Victor H. v. United Airlines Inc
216 F.3d 1111 (D.C. Circuit, 2000)
Lemon v. Geren
514 F.3d 1312 (D.C. Circuit, 2008)
American Bar Ass'n v. Federal Trade Commission
636 F.3d 641 (D.C. Circuit, 2011)
Already, LLC v. Nike, Inc.
133 S. Ct. 721 (Supreme Court, 2013)
United States v. Commonwealth Edison Co.
620 F. Supp. 1404 (N.D. Illinois, 1985)
Sierra Club v. Browner
130 F. Supp. 2d 78 (District of Columbia, 2001)
Grand Lodge of the Fraternal Order of Police v. Ashcroft
185 F. Supp. 2d 9 (District of Columbia, 2001)
Basel Action Network v. Maritime Administration
370 F. Supp. 2d 57 (District of Columbia, 2005)
Physicians Committee for Responsible Medicine v. Horinko
285 F. Supp. 2d 430 (S.D. New York, 2003)
Joseph Arpaio v. Barack Obama
797 F.3d 11 (D.C. Circuit, 2015)
Yassin Aref v. Loretta Lynch
833 F.3d 242 (D.C. Circuit, 2016)